Related by context. All words. (Click for frequent words.) 68 ZEGERID Capsules 67 Fast Track designations 67 KYNAPID 67 Act PDUFA date 66 assigned PDUFA 66 Oral Calcitonin 66 Mylan Receives Approval 66 Telik logo TELINTRA 65 Application BLA 65 Risperidone Oral Solution 65 Application MAA 65 PDUFA Date 65 liver resection surgeries 65 highly purified pasteurized 64 granted Ortec 64 Intermezzo ® NDA 64 Dementia Related Psychosis 64 Metformin HCl 64 alvimopan 64 treat atrial flutter 64 Submits Biologics License Application 64 severe hypercholesterolemia 64 REMOXY NDA 64 oral methylnaltrexone 64 albiglutide 63 FDA approvable letter 63 GRALISE 63 oxymorphone ER 63 Phenoptin 63 5 lipoxygenase inhibitor 63 ENRICH trial 63 Complete Response 63 octreotide acetate 63 Submits NDA 63 Pivotal Phase III 63 supplemental Biologics License Application 63 NDA Submission 63 Announces Tentative Approval 63 MAGE A3 ASCI 63 Pegloticase 63 BEMA ® 63 mesylate tablets approved 63 SPARLON 63 Metformin GR 63 Known hypersensitivity 63 CORLUX CORT # 63 balsalazide tablet 63 pulls Darvon painkiller 63 Biological License Application 63 testosterone gel LibiGel 63 nasal calcitonin product 63 commercialize oritavancin 62 FDA Accepts 62 Impax ANDA 62 Pivotal Phase 62 Marketing Authorisation Application MAA 62 PRN FDA Approves 62 Contrave NDA 62 Entereg R 62 Biologic License Application 62 Oracea TM 62 Submits Response 62 Initiate Phase 62 Ambrisentan 62 pentadentate logo R 62 authority Gurian Sherman 62 pantoprazole sodium 62 Act PDUFA guidelines 62 successfully commercialize Iluvien 62 Acetavance TM 62 sNDAs 62 Namenda XR 62 Generic Version 62 Barr ANDA 62 brand ciclesonide HFA 62 Meets Primary Endpoint 62 FDA Approvable Letter 62 novel orally inhaled 62 venlafaxine ER 62 vapreotide acetate 62 NicVAX TM 62 PROVENGE ® 62 T Pred 62 DULERA 62 Amigal TM 62 SILENOR TM 62 Keppra ® XR 62 designated cethromycin 62 Approvable 62 Marketing Authorization Application MAA 61 oral dual endothelin 61 Marketing Authorization Application 61 Stavzor 61 Prestara 61 BRINAVESS 61 Granted Orphan Drug 61 BRILINTA 61 Horizant ™ 61 Crofelemer budesonide foam 61 Exocrine Pancreatic Insufficiency 61 TELINTRA 61 Paliperidone Palmitate 61 alogliptin 61 STELARA TM 61 ABILIFY Injection 61 Coadministration 61 interferon gamma 1b 61 post operative ileus 61 Linjeta TM 61 lintuzumab SGN 61 Emezine 61 Second Pivotal Phase 61 GTC recombinant human 61 Long acting beta2 61 Zolpimist 61 supplemental biologics 61 Fast Track Status 61 balsalazide disodium 61 Completes Patient Enrollment 61 Tarceva TM 61 markets HP Acthar 61 Initiates Enrollment 61 QNEXA 61 icatibant 61 Zenvia ™ 61 ACTEMRA TM 61 oral rivaroxaban 61 PEGINTRON TM 61 Submits Supplemental 61 APF# NDA 61 SILENOR 61 LymphoStat B belimumab 61 PROMACTA ® 61 dopamine receptor agonist 61 Icatibant 61 recombinant PSMA vaccine 61 BLA filing 61 CIP TRAMADOL ER 61 PEGylated anti 61 please visit http:/www.atherogenics.com 61 PNP inhibitor 61 RANK Ligand inhibitor 61 Receives Approvable Letter 61 GTC recombinant form 61 designated Restanza 61 Mg Usa 61 Empatic ™ 61 Tasigna nilotinib 61 Sanctura XR 61 Marketing Authorisation Application 61 Budesonide foam crofelemer 61 XL# anticancer compounds 61 Inhalation Aerosol 61 ISO Vorin TM 61 lucinactant 61 ADVERSE EVENTS 61 MAA submission 61 candidate XP# 61 sNDA submission 61 nanofiltered plasma derived 61 GATTEX TM 61 Vitrasert R 61 VIMOVO 61 Silenor ® doxepin 61 Initiates Phase III 61 SUSTENNA TM 61 Hiberix 61 CERVARIX R 60 SWX BSLN 60 R rilonacept Injection 60 combines bupropion 60 Inc. www.micromet inc.com 60 ruxolitinib 60 Severe hypersensitivity reactions 60 Q#IR 60 INVEGA ® 60 Unit Dose Budesonide 60 Febuxostat 60 Gel repository corticotropin injection 60 #mg/day [002] 60 steroid refractory GvHD 60 PLAVIX R clopidogrel bisulfate 60 GENERIC SILDENAFIL SOFT Generic 60 Lamictal ODT 60 methylnaltrexone bromide 60 markets COLAZAL 60 FACTIVE R gemifloxacin 60 Xcytrin R 60 Biologics License Application BLA 60 Romiplostim 60 miconazole MBT 60 Mg Uk 60 Divalproex Sodium 60 Tezampanel 60 sitaxsentan sodium 60 includes TOLAMBA TM 60 Zenpep 60 Nabi HB Intravenous 60 accompanying electrolyte abnormalities 60 ATPace TM 60 Receives Orphan Drug Designation 60 AAG geldanamycin analog 60 ANDA Filing 60 PRECISE Trial 60 Files Investigational 60 DORIBAX 60 signal detection CTSD 60 Orapred ODT 60 SinuNase TM 60 Phase IIb Trial 60 ARCOXIA 60 Approvable Letter 60 VIVITROL ® 60 Approvable letter 60 Solzira TM 60 Randomized Phase 60 ZOLINZA 60 containing LABAs 60 PROVENGE sipuleucel T 60 Orphan Drug designations 60 Testosterone MDTS ® 60 Grants Orphan Drug 60 generation purine nucleoside 60 oral prodrug 60 Dexilant 60 paliperidone palmitate 60 FDA Complete Response 60 Biologics License Application 60 R lenalidomide 60 Belimumab 60 Through Glycoscience R 60 Emtriva Viread 60 Premarket Approval Application 60 Eszopiclone 60 Frova ® 60 Pruvel 60 onabotulinumtoxinA 60 pseudobulbar affect PBA 60 TRIOLEX HE# APOPTONE HE# 60 DIFICID ™ 60 Silenor NDA 60 NasdaqGM NTEC today 60 zafirlukast 60 cinacalcet HCl 60 Zensana 60 Investigational Device Exemption 60 Toremifene 60 oral ridaforolimus 60 Kynapid 60 Cellegesic 60 OMNARIS Nasal Spray 60 Tibotec Therapeutics division 60 Begins Dosing 60 non constipation irritable 60 Receives Fast Track 60 Zolpidem Tartrate Tablets 60 Increlex TM 60 oral nucleoside analogue 60 Oracea ® 60 PDUFA date 60 Phase III Clinical Trial 60 OLpur TM H2H 60 5 HT3 antagonist 60 phase III isavuconazole 60 Vimpat R 60 Phase 2b Clinical Trial 60 OMAPRO ™ 60 cyclobenzaprine hydrochloride extended 60 receiving XGEVA 60 Luvox fluvoxamine 60 PDUFA Prescription Drug 60 include Phenoptin TM 60 buccal tablets 60 Accelerated Approval 60 nephropathic cystinosis cystinosis 60 metformin HCl 60 SURFAXIN 59 Files IND 59 Somatuline Autogel 59 successfully commercialize Silenor 59 Drug Eluting Stent System 59 candidate SILENOR TM 59 Complete Response letter 59 eprodisate Fibrillex TM 59 Novartis Galvus 59 Drug Application 59 virus HCV protease inhibitor 59 ALVESCO R 59 PROMACTA 59 Biologic License Application BLA 59 BEMA Granisetron 59 HCl PEPCID ® famotidine 59 Orathecin 59 ALN HPN 59 CYP#A# substrate 59 Surfaxin lucinactant 59 NYSE Amex PTN 59 Dyloject TM 59 Staphylococcus aureus Immune Globulin 59 R sipuleucel T 59 HPV vaccine GlaxoSmithKline Cervarix 59 Zytiga 59 Auxilium anticipates 59 oral hydromorphone 59 Zileuton 59 TO AVOID PREGNANCY WHILE 59 Taro Receives 59 metformin accumulation 59 synthetic lipoglycopeptide antibiotic 59 TYGACIL 59 allosteric modulator PAM 59 Submits Investigational 59 Presents Positive 59 venlafaxine hydrochloride 59 Levoleucovorin 59 Tasigna prolongs 59 MedWatch website 59 Pirfenidone 59 Impax generic 59 hoFH 59 Ramelteon 59 corticotropin injection 59 Entereg alvimopan 59 Hematide ™ 59 rufinamide 59 severe gastroparesis 59 anidulafungin 59 website http:/www.depomed.com 59 Combination REOLYSIN R 59 Emezine R 59 sBLA filings 59 SILENOR ™ 59 Cardium Therapeutics TM 59 blood thinner prasugrel 59 Investigational Oral 59 tafamidis 59 adjuvant GIST 59 LibiGel ® 59 IAP inhibitor 59 INSPIRE Trial Phase III 59 REBETOL combination therapy 59 SPRYCEL ® 59 Personalized Immunotherapy 59 Octreolin 59 EVIZON TM 59 Nasdaq DVAX 59 zileuton CR 59 Esbriet ® 59 Anidulafungin 59 Junovan 59 proprietary transdermal patch 59 Orphan Drug Status 59 ULTRASE 59 Efficacy Results 59 Exalgo TM 59 Certolizumab 59 Phase 2a Trial 59 Schering Plough Remicade 59 proprietary intravenous formulation 59 rasagiline tablets 59 Sumatriptan Succinate 59 palonosetron hydrochloride injection 59 Methylnaltrexone 59 Launches Generic Version 59 HFA MDI 59 ZEGERID Powder 59 Anturol TM 59 Aloprim TM allopurinol sodium 59 Omigard 59 novel trazodone formulation 59 Cerezyme Fabrazyme Myozyme Aldurazyme 59 TRANSDUR ® 59 Somatuline Depot 59 TAXUS Element Paclitaxel Eluting 59 Submits IND 59 Fibrillex TM 59 Initiate Phase III 59 Achieves Primary Endpoint 59 contains benzyl alcohol 59 Cholesterol Lowering Drug 59 Excellarate TM 59 Symbyax 59 compound INCB# 59 Nicotine Conjugate Vaccine 59 Asentar TM 59 Premarket Approval PMA 59 Drug Submission 59 Roflumilast 59 Brentuximab Vedotin SGN 59 bazedoxifene 59 tacrolimus capsules 58 Vertex hepatitis C 58 NEBIDO 58 Issues Complete Response 58 heterozygous FH 58 Loceryl ® 58 sitaxsentan 58 terlipressin 58 mesylate tablets 58 application sNDA 58 Pruvel ™ prulifloxacin 58 Noxafil 58 dasatinib Sprycel ® 58 Kamada AAT 58 ACUROX ® 58 injectable formulation 58 MK #B 58 Resubmission 58 Trexima 58 Visit www.fda.gov medwatch 58 proprietary Capillary Aerosolization Technology 58 hydrochloride extended 58 submitted Marketing Authorization 58 Lexapro Effexor Serzone 58 fingolimod 58 OMP designation 58 Levaquin levofloxacin 58 guanfacine extended release 58 approvable letters 58 solanezumab 58 sNDA 58 octreotide implant 58 Marketing Approval PMA 58 Board DSMB 58 investigational antiplatelet agent 58 inhibitor PPI 58 gabapentin enacarbil 58 rabeprazole sodium 58 Expanded Indication 58 Ocrelizumab 58 HoFH 58 solid tumors ZYBRESTAT 58 Kiacta 58 JAK2 Inhibitor 58 6R BH4 58 PDE4 inhibitor 58 sBLA 58 novel MetAP 2 58 sumatriptan succinate injection 58 Panzem R 58 Investigational Compound 58 commercialized DURECT 58 YOUR LOCAL ANIMAL SHELTER 58 Supplemental Biologics License Application 58 Zidovudine Tablets 58 naproxen esomeprazole magnesium 58 Raptiva R 58 refractory chronic lymphocytic 58 PREOS R 58 BLA submission 58 Tablets #mg [002] 58 Contrave# 58 BioGlue R 58 Zegerid OTC 58 fluvoxamine maleate 58 casopitant 58 #D#C# 58 Ticagrelor 58 developing ACAPODENE 58 hyperphenylalaninemia HPA due 58 Meloxicam Tablets 58 PrevOnco 58 Genentech Wyeth Pharmaceuticals 58 Firazyr 58 postherpetic neuralgia PHN 58 IND Filing 58 Not Approvable 58 Investigational Treatment 58 5 HT2A inverse 58 DASISION 58 Tekamlo 58 Cethromycin 58 anaphylactic reactions bronchospasm 58 Corlux 58 Act PDUFA 58 Entereg 58 oral vancomycin 58 Keppra XR 58 #k PMA sNDA 58 Cipro XR 58 MEK Inhibitor 58 RAPTIVA 58 requiring Asthmatx 58 Viviant 58 Patient Enrollment 58 NUEDEXTA ™ 58 Plicera 58 REG1 Anticoagulation System 58 Inhaled Insulin 58 Bifeprunox 58 indiplon capsules 58 midstage clinical 58 CCR5 inhibitors entry 58 RoACTEMRA 58 Trobalt 58 inhaled formulation 58 Targretin capsules 58 cutaneous T 58 HCl capsules 58 recurrent metastatic ovarian cancer 58 Refractory Hodgkin Lymphoma 58 selective modulator 58 small molecule Hedgehog 58 k Premarket Notification 58 JOULFERON 58 TWYNSTA ® 58 Sycrest 58 Raptiva ® 58 OLEPTRO 58 Certriad 58 LibiGel NDA 58 torezolid phosphate 58 OctoPlus licensed 58 Prilosec omeprazole 58 R Saizen R 58 Glycopyrrolate 58 DATES Comments 58 cerebral oximeter available 58 Marketing Authorization Applications 58 ONTAK 58 lorcaserin NDA 58 Iluvien ® 58 Recombinant Human 58 anthracycline taxane 58 approve Arcoxia 58 Luveniq 58 Avanafil 58 FDA APPROVES 58 IND Investigational New 58 chronic idiopathic thrombocytopenic purpura 58 website www.depomed.com 58 PrandiMet TM 58 myelodysplastic myeloproliferative diseases 58 Lenocta TM 58 norepinephrine reuptake inhibitor 58 diarrhea predominant irritable 58 CD# CEA 58 specifically hypoactive sexual 58 Exelbine NDA 58 esomeprazole magnesium 58 Phase 2b Trial 58 R sorafenib tablets 58 quetiapine fumarate 58 ENL recurrence 58 postoperative ileus POI 58 Genasense ® oblimersen 58 Pfizer maraviroc 58 HCl Injection 58 Annual Required Filings 58 Torisel 58 PRISTIQ 58 FUSILEV ® 58 ATryn ® 58 Zelrix 58 SomatoKine 58 UCB Keppra 58 Marketing Authorisation 58 CONBRIZA 58 DAYTRANA TM 58 Initiates Phase II 58 Cutaneous T 58 Asmanex 57 DEXILANT 57 banned Darvon Darvocet 57 approve Zenvia 57 Hematide ™ peginesatide 57 faropenem medoxomil 57 efalizumab 57 Proquin XR 57 baminercept 57 BiovaxID TM 57 Fast Track designation 57 Gralise 57 Adcirca 57 Tekturna HCT ® 57 Gestiva TM 57 Hormone Refractory Prostate Cancer 57 Warner Chilcott Actonel 57 dependent kinase inhibitor 57 Nasdaq NPSP announced 57 laropiprant 57 dihydrochloride Tablets 57 pancrelipase 57 Fortical R 57 DEB# 57 Marketing Authorization 57 NVA# 57 Acurox r Tablets 57 ELADUR ™ 57 Orphan Drug status 57 Repros Therapeutics Inc 57 Requip XL 57 losartan potassium 57 pioglitazone HCl 57 Pivotal Clinical Trial 57 CYT# potent vascular disrupting 57 Lamotrigine Tablets 57 CYP#A# CYP#D# 57 FOLOTYN ® 57 gastrointestinal mucositis 57 Tesamorelin 57 Dose Ranging Study 57 Sprycel dasatinib 57 Extina 57 Inc. Nasdaq CRTX 57 Pivotal Trial 57 ® decitabine 57 pulmonology portfolio 57 beta 1a 57 Treximet 57 intravesical infusion therapy 57 LSE SHP.L 57 gave Makena orphan 57 Silodosin 57 Zalbin 57 Besivance 57 severe hypersensitivity reactions 57 Phase 2a Clinical Trial 57 PRADAXA 57 PIX# trial 57 levocetirizine 57 methylnaltrexone 57 cangrelor 57 FIRAZYR 57 website www.nyandcompany.com 57 Solzira 57 REMINYL ® 57 INTUNIV TM 57 Sular formulation 57 QNEXA ® 57 Glufosfamide 57 Egrifta 57 Nasdaq CYCC Nasdaq CYCCP 57 novel VDA molecule 57 Tasimelteon 57 Theratechnologies Announces 57 Angiox ® 57 pralatrexate injection folate analogue 57 pharmacogenomic translational research 57 Diabetic Macular Edema 57 Nebido 57 investigational humanized monoclonal antibody 57 First Patient Enrolled 57 BLOOM DM 57 Friedreich Ataxia FRDA 57 miconazole Lauriad R 57 Talabostat 57 Fortigel 57 REVLIMID R 57 Panflu TM Sinovac 57 submitted supplemental Biologics 57 Fast Track Designation 57 Velaglucerase Alfa 57 FROVA 57 Voraxaze 57 ORENCIA R 57 Topiramate Tablets 57 Focalin XR ® 57 Clinical Trials Update 57 Daytrana ® 57 IV acetaminophen 57 Phase IIb Clinical Trial 57 novel synthetic PEGylated 57 ONGLYZA ™ 57 Glatiramer Acetate 57 AGILECT R 57 By JAMAAL ABDUL 57 SPRIX ® 57 granisetron hydrochloride 57 dopamine partial agonist 57 Nasdaq OSCI 57 orphan medicinal product 57 ATryn R 57 Roche Boniva 57 Prostate AdenoCarcinoma Treatment 57 Premarket Approval 57 Phase III placebo controlled 57 zolpidem tartrate sublingual tablet 57 INTUNIV TM guanfacine extended 57 Stedivaze 57 Zorbtive TM 57 ORENCIA ® 57 ABILIFY ® 57 completed Abrames 57 R MSCRAMM 57 catheter occlusion 57 Phase IIIb clinical 57 oxypurinol 57 Amrubicin 57 STERIS Corporation Announces 57 Ophena TM 57 Illusionist Toy Story 57 alfa 2a 57 Presents Preclinical 57 autologous cellular immunotherapy 57 Saforis 57 ZALBIN 57 novel emulsion formulation 57 Sapacitabine 57 XP# XP# 57 COLAZAL ® 57 prodrug stimulant 57 Pirespa 57 ZANAFLEX CAPSULES ® tizanidine 57 Triapine R 57 Neurodex 57 Oxcarbazepine 57 5mg #mg #mg 57 Zelapar 57 Antidepressant Drug 57 serotonin norepinephrine reuptake inhibitor 57 Release Capsules 57 treat opioid induced 57 Aflibercept 57 lesinurad 57 eltrombopag 57 RHUCIN 57 Lilly Cymbalta 57 mg dosages 57 Completes Enrollment 57 Morphine Sulfate 57 nonhematologic adverse reactions 57 multicenter Phase III 57 Cladribine 57 ENTEREG ® 57 Cytogen marketed 57 dextromethorphan quinidine 57 Biomerix Corporation 57 miconazole Lauriad ® 57 sorafenib tablets 57 TBC# 57 including eniluracil ADH 57 REMICADE ® 57 desvenlafaxine succinate 57 Auxilium Pharma 57 Saxagliptin 57 Arzerra TM 57 Staccato loxapine 57 HGS ETR1 mapatumumab 57 Pafuramidine 57 acyclovir Lauriad R 57 Entereg TM 57 Receives Complete Response 57 visilizumab 57 Inc. NASDAQ NEOL 57 adenosine injection 57 Rotarix ® 57 AVASTIN 57 subcutaneous formulation 57 Nasdaq PGNX today 57 Ketotransdel ® 57 IV APAP 57 velaglucerase alfa 57 tolevamer 57 submitted Biologics License 57 LymphoStat B TM 57 Orphan Status 57 citalopram hydrobromide 57 Somatuline R Autogel R 57 Loxapine 57 Clinical Trial Evaluating 57 Genasense R oblimersen 57 oral antihistamine 57 Fortovase 57 Paxil paroxetine 57 Oracea R 57 Kit CD# positive 57 Horizant 57 VERTEX PHARMACEUTICALS 57 ALVESCO HFA 57 PREOS 57 TOPAMAX R 57 RSD# oral 57 faropenem 57 Indevus Pharma 57 arsenic trioxide injection 57 zileuton 57 Stedesa 57 developing Zerenex ferric 57 dirucotide 57 IG HCR ;) CO 57 CRMD# 57 Linjeta 57 Exelbine 57 New Drug Application 57 riociguat 57 BENLYSTA ® 57 intranasal formulation 57 Reclast Aclasta 57 MCSP respectively 57 Ixempra 57 Demonstrates Significant 57 multi kinase inhibitor 57 TM pralatrexate injection 57 FACTIVE tablets 57 homozygous familial hypercholesterolemia 57 NESINA 57 Extended Release 57 Dasatinib 57 Abbott Laboratories Depakote 57 evaluating picoplatin 57 confirmatory clinical 57 label Lipofen R 57 Receives Orphan Drug 57 diarrhea fatigue asthenia 57 Liprotamase 57 Orphan Drug designation 57 MICHAEL MCANDREWS HARTFORD COURANT 57 Zenvia Phase III 57 ingredients decongestants expectorants 57 Humanitarian Device Exemption 57 please visit www.medicinova.com 56 CEFF financings subject 56 AMPAKINE CX# 56 panitumumab Vectibix 56 palonosetron hydrochloride Injection Dacogen 56 maribavir 56 AMEVIVE 56 Advagraf 56 Roche Actemra 56 Amlodipine Besylate 56 Dupuytren Contracture 56 non nucleoside inhibitor 56 Iloperidone 56 pyrimidine nucleoside analog 56 TORISEL 56 Sunesis Pharma 56 By Ruza Zivkusic 56 Ropinirole 56 Receives Positive Opinion 56 generic Lipitor 56 milnacipran 56 Anti Infective Drugs 56 REGN# 56 ANCHOR trial 56 oxandrolone USP 56 GATTEX ™ 56 AZILECT R 56 Inc. Nasdaq CYCC 56 rilonacept 56 PANVAC VF 56 Gamunex C 56 Jevtana 56 mild vasodilator 56 Troxatyl 56 IL# PE#QQR 56 diabetic peripheral neuropathic DPN 56 IND Application 56 acceptable expertizing authority 56 HZT 56 agonistic human 56 BioDelivery Sciences 56 Earns Milestone Payment 56 markets Testim ® 56 CIMZIA TM 56 BioSante Pharmaceuticals Announces 56 GSK# [001] 56 treat chronic sinusitis 56 herpetic keratitis 56 rhThrombin 56 Xolegel 56 ELADUR 56 Stavzor ™ 56 orally bioavailable compound 56 Oral Solution 56 StaphVAX R 56 formerly LymphoStat B 56 Wellbutrin XL ® 56 OFIRMEV 56 Mylan ANDA 56 CoTherix logo 56 acetonide FA 56 pediatric exclusivity 56 FOSAMAX PLUS D 56 mGluR5 NAM 56 mertansine 56 COLAZAL R 56 vinorelbine emulsion 56 VALSTAR 56 patient derived xenografts 56 Keppra XR TM 56 mGluR5 negative 56 IMiDs 56 systemic anaplastic large 56 Drug Candidate 56 zileuton IV 56 Generic Version Of 56 NOXAFIL 56 mycophenolic acid 56 Extended Release Capsules 56 hypercalcemia 56 topical gel formulation 56 HCV NS5B polymerase 56 Rivaroxaban 56 oxaliplatin Eloxatin 56 BioGlue ® 56 Pixuvri 56 lumiliximab 56 KIACTA ™ 56 NDA submission 56 Wellbutrin XL R 56 telavancin NDA 56 maximally tolerated dose 56 candidate deforolimus 56 Market Authorization Application 56 eg NDA BLA 56 squalamine 56 Exalgo 56 please visit www.middlebrookpharma.com 56 dihydrochloride Phase 3 56 Fondaparinux 56 SYCREST 56 mGluR2 positive 56 evaluating mipomersen 56 Company Nasdaq PRGO 56 Riquent 56 Nasdaq EPCT 56 Phase IIb trials 56 please visit http:/www.vandapharma.com 56 TELINTRA R 56 Soliris TM eculizumab 56 Aztreonam Lysine 56 INVEGA ® SUSTENNA ® 56 ATPace 56 ULTRAM ER 56 SAR# [004] 56 Interferon beta 1b 56 Neupro R 56 Ofatumumab 56 bevirimat Study 56 Vfend 56 R vancomycin hydrochloride 56 Kuvan R 56 oral cladribine 56 ACTIQ ® 56 Testosterone Gel 56 Cleviprex TM clevidipine 56 Zerenex 56 Plaque Psoriasis 56 Otelixizumab 56 Sanvar R 56 Xeloda ® 56 Schizophrenia Drug 56 oral FTY# 56 Receives Tentative FDA 56 pioglitazone hydrochloride 56 inhibit oxidative stress 56 TORISEL TM 56 Octreotide 56 worsening thrombocytopenia 56 read Palintologist 56 developing ostarine selective 56 Arthritis Drugs 56 #mg #mg #mg #mg [002] 56 TAXUS Element Stent System 56 phase IIb clinical 56 sapropterin dihydrochloride 56 k premarket 56 ULORIC 56 metoprolol succinate 56 R galsulfase 56 Vandetanib 56 subsidiaries visit http:/www.apricusbio.com 56 headache nasopharyngitis 56 VISICOL R 56 human C1 inhibitor 56 confirmatory Phase III 56 Cimzia TM 56 induce orthostatic hypotension 56 events thrombocytopenia neutropenia 56 OAB overactive bladder 56 antiplatelet agent 56 Arikace 56 SinuNase ™ 56 MAXY alpha 56 SNT MC# 56 elotuzumab 56 Naglazyme R 56 Arzerra ofatumumab 56 AstraZeneca Symbicort 56 KRYSTEXXA TM 56 TYKERB 56 SinuNase 56 antidiabetic drug 56 FDA Orphan Drug 56 intravenous acetaminophen 56 Extended Release Tablets 56 Cariprazine 56 Inc. Nasdaq VNDA 56 bile duct tumor 56 paliperidone ER 56 relapsed MCL 56 PLX STROKE targeting 56 YONDELIS 56 singer Jazzie B. 56 Priority Review 56 BYETTA ® 56 vernakalant iv 56 Cimzia ® certolizumab pegol